S. 1954: Biosimilar Red Tape Elimination Act

S. 1954 is a federal bill in the 119th Congress. Today, a biological drug that is very similar to a brand-name reference product must go through extra testing to be officially designated as interchangeable, which allows a pharmacist to swap it for the brand-name version. Under this bill, every biosimilar… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.